Koselugo Alternatives Compared
Koselugo | Selumetinib | Bevacizumab |
|
---|
Koselugo (selumetinib) | Selumetinib | Bevacizumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Neurofibromatosis. Koselugo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neurofibromatosis. selumetinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glioblastoma Multiforme, Colorectal Cancer, Fallopian Tube Cancer, Cervical Cancer, Breast Cancer - Metastatic, Breast Cancer, Hepatocellular Carcinoma, Macular Degeneration, Malignant... View more |
||||||||
More about Koselugo (selumetinib) | More about Selumetinib | More about Bevacizumab | ||||||||
Ratings & Reviews | ||||||||||
Koselugo has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Selumetinib has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Bevacizumab has an average rating of 7.8 out of 10 from a total of 37 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Koselugo side effects in more detail. |
See also: selumetinib side effects in more detail. |
See also: bevacizumab side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
View all Koselugo prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | ||||||||||
|
N/A |
N/A |
||||||||
Brand Names | ||||||||||
N/A |
Koselugo | Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
6.2 hours |
6.2 hours |
480 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 224 drugs are known to interact with Koselugo:
|
A total of 224 drugs are known to interact with selumetinib:
|
A total of 45 drugs are known to interact with bevacizumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
April 10, 2020 |
April 10, 2020 |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.